» Articles » PMID: 25823931

Gastric Mixed Adenoneuroendocrine Carcinoma with Thyroid Transcription Factor-1-positive Neuroendocrine Component

Overview
Specialty Gastroenterology
Date 2015 Apr 1
PMID 25823931
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Small cell carcinoma of the stomach, which is considered synonymous with neuroendocrine carcinoma, is rare. We encountered a case of mixed adenoneuroendocrine carcinoma. Gastrointestinal endoscopy revealed a type 0 IIa + IIc lesion in the stomach. Biopsy suggested well-differentiated adenocarcinoma. Endoscopic submucosal dissection was performed and gastric cancer comprising both well to moderately differentiated adenocarcinoma within the mucous membrane and small cell carcinoma invading to the submucosa with accompanying vessel invasion was found. Mixed adenoneuroendocrine carcinoma was diagnosed and the small cell carcinoma was thyroid transcription factor-1 positive. No tumor lesions were apparent in other organs, so distal gastrectomy and lymph node dissection were performed. Lymph node metastases were not observed. The patient is currently alive without recurrence. Thyroid transcription factor-1-positive gastric neuroendocrine carcinoma is very rare, and the thyroid transcription factor-1-positive rate may contribute to the prediction of prognosis and treatment selection. Accumulation of cases is thus very important.

Citing Articles

Clinical characteristics of early neuroendocrine carcinoma in stomach: A case report and review of literature.

Zhu X, Jing H, Yao T Medicine (Baltimore). 2019; 98(30):e16638.

PMID: 31348317 PMC: 6709248. DOI: 10.1097/MD.0000000000016638.

References
1.
Hosokawa A, Shimada Y, Shirao K, Matsumura Y, Yamada Y, Muro K . Long-term survivor of gastric small cell carcinoma. Hepatogastroenterology. 2004; 51(59):1567-70. View

2.
Tsushima T, Tsuji Y, Abe S, Tamura F, Mizushima T, Nagashima H . [A case of metastatic gastric endocrine cell carcinoma which could be curably resected after chemotherapy with S-1/CDDP]. Gan To Kagaku Ryoho. 2008; 35(5):817-20. View

3.
Poiana C, Carsote M, Ardeleanu C, Terzea D, Avramescu E, Neamtu M . The value of the immunohistochemistry in a case of gastric neuroendocrine tumor and thyroid metastasis. Rom J Morphol Embryol. 2011; 52(1):187-92. View

4.
Agoff S, Lamps L, Philip A, Amin M, Schmidt R, True L . Thyroid transcription factor-1 is expressed in extrapulmonary small cell carcinomas but not in other extrapulmonary neuroendocrine tumors. Mod Pathol. 2000; 13(3):238-42. DOI: 10.1038/modpathol.3880044. View

5.
Hanada N, Inoue K, Osako T, Kuriwaki K, Shimajiri S, Mochinaga M . [A case of partial response in liver metastatic lesion from gastric endocrine cell carcinoma treated with TS-1]. Gan To Kagaku Ryoho. 2006; 33(8):1143-6. View